Dr. Cornelius Cano Ssemakalu is an Associate Professor of Cell Biology at Vaal University of Technology and co-founder of Iraka Biotech. With over 14 years of experience, his work focuses on pathogen inactivation and vaccine development. He developed Photonics Inactivation Technology (PIT™), a safer and more efficient method for vaccine production. Dr. Ssemakalu has collaborated with institutions such as the Jenner Institute at Oxford University, exploring the immunological effects of irradiated pathogens. His research also includes partnerships with the Institute of Aquatic Research at Stirling University, Cochin University of Science & Technology, and Kerala University of Fisheries and Ocean Studies, where he investigated the application of PIT™ for an aquatic pathogen. At Iraka Biotech, Dr. Ssemakalu is working towards integrating PIT™ into commercial vaccine production, aiming to demonstrate its effectiveness and scalability. His goal is to improve vaccine safety and accessibility, particularly in areas with limited resources. Dr. Ssemakalu's dedication to advancing vaccine technology and public health is evident through his innovative research and collaborative efforts. His contributions are crucial in developing safer, more accessible vaccines to combat emerging infectious diseases, ultimately enhancing global health outcomes.